UY31716A1 - Composiciones farmacéuticas que presentan un nivel deseado de biodisponibilidad - Google Patents
Composiciones farmacéuticas que presentan un nivel deseado de biodisponibilidadInfo
- Publication number
- UY31716A1 UY31716A1 UY031716A UY31716A UY31716A1 UY 31716 A1 UY31716 A1 UY 31716A1 UY 031716 A UY031716 A UY 031716A UY 31716 A UY31716 A UY 31716A UY 31716 A1 UY31716 A1 UY 31716A1
- Authority
- UY
- Uruguay
- Prior art keywords
- present
- pharmaceutical compositions
- biodisponibility
- desired level
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El presente invento se refiere a la provisión de composiciones farmacéuticas. Las composiciones contienen un agente terapéutico y una cantidad relativamente baja de agente tensioactivo para proporcionar una mayor biodisponibilidad del agente terapéutico. Las composiciones son particularmente deseables como composiciones oftálmicas en las que el agente terapéutico es un prostaglandina tal como travoprost y el agente tensioactivo es un aceite vegetal tal como aceite de ricino.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3711708P | 2008-03-17 | 2008-03-17 | |
US11192008P | 2008-11-06 | 2008-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31716A1 true UY31716A1 (es) | 2009-08-31 |
Family
ID=41037889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY031716A UY31716A1 (es) | 2008-03-17 | 2009-03-16 | Composiciones farmacéuticas que presentan un nivel deseado de biodisponibilidad |
Country Status (24)
Country | Link |
---|---|
US (5) | US20090234004A1 (es) |
EP (4) | EP2705836A1 (es) |
JP (2) | JP5654444B2 (es) |
KR (1) | KR101586357B1 (es) |
CN (2) | CN105012964A (es) |
AR (1) | AR070888A1 (es) |
AU (1) | AU2009225824B2 (es) |
BR (1) | BRPI0908717B1 (es) |
CA (1) | CA2716994C (es) |
CL (1) | CL2009000624A1 (es) |
DE (2) | DE202009019087U1 (es) |
DK (3) | DK2599475T3 (es) |
ES (3) | ES2635197T3 (es) |
HK (2) | HK1212605A1 (es) |
HU (1) | HUE025619T2 (es) |
MX (1) | MX2010009570A (es) |
PL (1) | PL2265251T3 (es) |
PT (1) | PT2265251E (es) |
RU (1) | RU2503453C2 (es) |
SI (1) | SI2265251T1 (es) |
TW (1) | TWI544927B (es) |
UY (1) | UY31716A1 (es) |
WO (1) | WO2009117316A2 (es) |
ZA (1) | ZA201006227B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009117242A2 (en) | 2008-03-17 | 2009-09-24 | Alcon Research, Ltd. | Aqueous pharmaceutical compositions containing borate-polyol complexes |
TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
TWI489997B (zh) | 2009-06-19 | 2015-07-01 | Alcon Res Ltd | 含有硼酸-多元醇錯合物之水性藥學組成物 |
KR20130094293A (ko) * | 2010-07-21 | 2013-08-23 | 알콘 리서치, 리미티드 | 향상된 용해도 특성들을 갖는 약학 조성물 |
EP2452669A1 (en) | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
EP2887923B1 (en) * | 2012-08-24 | 2023-04-05 | Sun Pharmaceutical Industries Limited | Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions |
EP3096740B1 (en) * | 2014-01-24 | 2020-09-30 | Sentiss Pharma Private Limited | Pharmaceutical composition comprising brinzolamide |
EP2937076B1 (en) * | 2014-04-25 | 2019-09-11 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Eye drops containing prostaglandin and tyloxapol |
AU2015264181A1 (en) * | 2014-05-23 | 2016-12-01 | Ocular Technologies Sarl | Topical formulations and uses thereof |
US11285163B2 (en) | 2014-10-20 | 2022-03-29 | Sentiss Pharma Private Limited | Ophthalmic solution |
US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
EP4364810A3 (en) | 2015-11-10 | 2024-07-24 | Sun Pharmaceutical Industries Limited | Topical formulations and uses thereof |
WO2017083410A1 (en) * | 2015-11-12 | 2017-05-18 | Ocular Technologies Sarl | Topical formulations and uses thereof |
PT3423076T (pt) | 2016-02-29 | 2024-07-01 | Sun Pharmaceutical Ind Ltd | Formulações tópicas contendo ciclosporina e respetivas utilizações |
EP3861985B1 (en) | 2020-02-06 | 2023-06-14 | Ocular Therapeutix, Inc. | Compositions and methods for treating ocular diseases |
TWI819317B (zh) * | 2021-06-07 | 2023-10-21 | 溫士頓醫藥股份有限公司 | 含前列腺素衍生物的眼用奈米乳劑組合物 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3711708A (en) | 1971-02-25 | 1973-01-16 | Optical Coating Laboratory Inc | Rapid scan identifier for use in infrared absorption spectroscopy |
US4027020A (en) | 1974-10-29 | 1977-05-31 | Millmaster Onyx Corporation | Randomly terminated capped polymers |
US3931319A (en) | 1974-10-29 | 1976-01-06 | Millmaster Onyx Corporation | Capped polymers |
GB2084870B (en) | 1980-10-10 | 1985-05-09 | Muhlemann R Hans | Oral compositions containing pyrimidine amine compounds and zinc salts |
US4407791A (en) | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
US4525346A (en) * | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
US4836986A (en) * | 1984-09-28 | 1989-06-06 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
US5037647A (en) | 1988-09-15 | 1991-08-06 | Alcon Laboratories, Inc. | Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride |
US5145643A (en) | 1990-01-05 | 1992-09-08 | Allergan, Inc. | Nonoxidative ophthalmic compositions and methods for preserving and using same |
US5221664A (en) | 1990-04-23 | 1993-06-22 | Magainin Pharmaaceuticals Inc. | Composition and treatment with biologically active peptides and toxic cations |
EP0564510A1 (en) | 1990-12-27 | 1993-10-13 | Allergan, Inc | Method and composition for disinfecting contact lenses |
US5932572A (en) * | 1992-02-21 | 1999-08-03 | Alcon Laboratories, Inc. | Topical anti-glaucoma compositions |
US5505953A (en) | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
US5300287A (en) | 1992-11-04 | 1994-04-05 | Alcon Laboratories, Inc. | Polymeric antimicrobials and their use in pharmaceutical compositions |
US5320843A (en) | 1992-12-10 | 1994-06-14 | Polymer Technology Corporation | Method for improving antibacterial properties of ophthalmic solutions |
WO1996003158A1 (en) | 1994-07-22 | 1996-02-08 | Alcon Laboratories, Inc. | Use of low molecular weight amino acids in ophthalmic compositions |
US5603929A (en) | 1994-11-16 | 1997-02-18 | Alcon Laboratories, Inc. | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
US6011062A (en) | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
AU4878996A (en) | 1995-03-20 | 1996-10-08 | Unilever Plc | Liquid cleansing formulations |
HU225329B1 (en) | 1996-09-12 | 2006-09-28 | Richter Gedeon Vegyeszet | Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity |
CA2270349A1 (en) * | 1996-11-01 | 1998-05-14 | Jesse A. May | Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma |
GB9624928D0 (en) | 1996-11-29 | 1997-01-15 | Lintrend Developments Ni Ltd | Fibrous products and their production |
US6071904A (en) | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
ES2262603T3 (es) | 1996-12-13 | 2006-12-01 | Alcon Laboratories, Inc. | Composiciones oftalmicas que comprenden aminoalcoholes. |
AR002194A1 (es) | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
CA2291777A1 (en) * | 1997-05-30 | 1998-12-03 | Merck & Co., Inc. | Ophthalmic compositions for treating ocular hypertension |
EP1011728B1 (en) * | 1998-07-14 | 2004-12-29 | Alcon Manufacturing, Ltd. | Polypropylene containers for prostaglandin products |
US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
US6034043A (en) * | 1999-04-20 | 2000-03-07 | Lever Brothers Company, Division Of Conopco, Inc. | Mild antimicrobial liquid cleansing formulations comprising polyvalent cation or cations for improving an antimicrobial effectiveness |
US6482799B1 (en) | 1999-05-25 | 2002-11-19 | The Regents Of The University Of California | Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial |
US20020009507A1 (en) | 2000-01-19 | 2002-01-24 | Alcon Universal Ltd. | Use of polyethoxylated castor oil for the treatment of dry eye |
ES2357551T3 (es) | 2000-09-13 | 2011-04-27 | Santen Pharmaceutical Co., Ltd. | Colirio. |
CA2430127C (en) | 2000-11-29 | 2010-04-20 | Novartis Ag | Aqueous disinfecting system comprising a microbicide and 1,3-bis(tris[hydroxymethyl]methylamino)propane |
JP2002332225A (ja) * | 2001-05-09 | 2002-11-22 | Lion Corp | 眼科用組成物 |
DE10222388A1 (de) * | 2001-05-22 | 2003-02-13 | Denso Corp | Kompressor mit veränderbarer Verdrängung |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
JP4863589B2 (ja) | 2001-09-28 | 2012-01-25 | ロート製薬株式会社 | 水性組成物 |
KR20050057251A (ko) * | 2002-09-09 | 2005-06-16 | 산텐 세이야꾸 가부시키가이샤 | 라타노프로스트를 유효 성분으로 하는 투명한 점안액 |
US7074827B2 (en) | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
WO2005011704A1 (ja) | 2003-07-31 | 2005-02-10 | Santen Pharmaceutical Co., Ltd. | プロスタグランジン含有製品 |
JP4453815B2 (ja) * | 2003-12-08 | 2010-04-21 | ライオン株式会社 | ドライアイ治療剤 |
JP2005247801A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 安定な点眼剤 |
WO2005102058A2 (en) | 2004-04-23 | 2005-11-03 | Mystic Pharmaceuticals, Inc. | Multiple unit dose drug delivery system |
GB0501192D0 (en) | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
EP2066300B2 (en) | 2006-09-28 | 2019-01-23 | Novartis Ag | Self-preserved aqueous pharmaceutical compositions |
US20080095863A1 (en) | 2006-10-24 | 2008-04-24 | Alcon Manufacturing Ltd. | 2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions |
WO2008052037A2 (en) | 2006-10-24 | 2008-05-02 | Alcon Research, Ltd. | Packaging materials for formulations containing 2-pyrrolidone derivatives |
JPWO2008096804A1 (ja) * | 2007-02-07 | 2010-05-27 | テイカ製薬株式会社 | ラタノプロスト含有点眼剤 |
TWI544927B (zh) * | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
EP4434392A2 (en) | 2019-05-31 | 2024-09-25 | Karsten Manufacturing Corporation | Golf bag convertible strap assembly |
-
2009
- 2009-03-12 TW TW098108014A patent/TWI544927B/zh active
- 2009-03-13 EP EP13184332.8A patent/EP2705836A1/en not_active Withdrawn
- 2009-03-13 AR ARP090100905A patent/AR070888A1/es not_active Application Discontinuation
- 2009-03-13 ES ES12193597.7T patent/ES2635197T3/es active Active
- 2009-03-13 HU HUE09722278A patent/HUE025619T2/en unknown
- 2009-03-13 RU RU2010142307/15A patent/RU2503453C2/ru active
- 2009-03-13 DK DK12193597.7T patent/DK2599475T3/en active
- 2009-03-13 DE DE202009019087.0U patent/DE202009019087U1/de not_active Expired - Lifetime
- 2009-03-13 EP EP09722278.0A patent/EP2265251B1/en active Active
- 2009-03-13 ES ES15202422.0T patent/ES2637028T3/es active Active
- 2009-03-13 US US12/403,543 patent/US20090234004A1/en not_active Abandoned
- 2009-03-13 WO PCT/US2009/037077 patent/WO2009117316A2/en active Search and Examination
- 2009-03-13 DK DK09722278.0T patent/DK2265251T3/en active
- 2009-03-13 CA CA2716994A patent/CA2716994C/en not_active Expired - Fee Related
- 2009-03-13 PT PT97222780T patent/PT2265251E/pt unknown
- 2009-03-13 KR KR1020107022614A patent/KR101586357B1/ko active IP Right Review Request
- 2009-03-13 SI SI200931225T patent/SI2265251T1/sl unknown
- 2009-03-13 JP JP2011500876A patent/JP5654444B2/ja active Active
- 2009-03-13 CN CN201510501617.6A patent/CN105012964A/zh active Pending
- 2009-03-13 EP EP12193597.7A patent/EP2599475B1/en active Active
- 2009-03-13 US US12/403,529 patent/US8178582B2/en active Active
- 2009-03-13 CN CN2009801092915A patent/CN101977588A/zh active Pending
- 2009-03-13 DE DE202009019114.1U patent/DE202009019114U1/de not_active Expired - Lifetime
- 2009-03-13 MX MX2010009570A patent/MX2010009570A/es active IP Right Grant
- 2009-03-13 BR BRPI0908717-6A patent/BRPI0908717B1/pt active IP Right Grant
- 2009-03-13 AU AU2009225824A patent/AU2009225824B2/en active Active
- 2009-03-13 EP EP15202422.0A patent/EP3042646B1/en not_active Revoked
- 2009-03-13 ES ES09722278.0T patent/ES2542728T3/es active Active
- 2009-03-13 PL PL09722278T patent/PL2265251T3/pl unknown
- 2009-03-13 DK DK15202422.0T patent/DK3042646T3/en active
- 2009-03-16 UY UY031716A patent/UY31716A1/es not_active Application Discontinuation
- 2009-03-16 CL CL2009000624A patent/CL2009000624A1/es unknown
-
2010
- 2010-08-31 ZA ZA2010/06227A patent/ZA201006227B/en unknown
-
2011
- 2011-10-04 US US13/252,255 patent/US8722735B2/en active Active
-
2012
- 2012-04-09 US US13/442,475 patent/US8754123B2/en active Active
-
2013
- 2013-10-23 JP JP2013219982A patent/JP2014012744A/ja not_active Withdrawn
-
2014
- 2014-05-01 US US14/267,668 patent/US9144561B2/en active Active
-
2016
- 2016-01-19 HK HK16100544.3A patent/HK1212605A1/zh unknown
- 2016-07-18 HK HK16108483.9A patent/HK1220378A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31716A1 (es) | Composiciones farmacéuticas que presentan un nivel deseado de biodisponibilidad | |
PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
PE20130216A1 (es) | Formulacion topica para un inhibidor de jak | |
CO6571913A2 (es) | Derivados de fumarato de ácido graso y sus usos | |
BR112012023421A2 (pt) | composição farmacêutica para tratamento de aumento de pressão intraocular | |
CO6361902A2 (es) | Composiciones de organogel y procesos para su producción | |
AR089274A1 (es) | Composicion de grasa | |
UY35040A (es) | Pirrolopirimidinilamino-benzotiazolonas sustituidas | |
GT201200024A (es) | Formulación subcutánea de anticuerpo anti-her2 | |
CR20120259A (es) | Espiroindolinona-pirrolidinas | |
AR081681A1 (es) | METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA | |
BR112013019257A2 (pt) | composição de androgênio para tratar uma condição oftálmica | |
BR112012033755A2 (pt) | composições e métodos antissépticos estáveis | |
BR112014010376A2 (pt) | medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima | |
BR112022004730A2 (pt) | Composição cosmética para cabelos e métodos de tratamento de cabelos | |
ECSP14013200A (es) | Una nueva composición terapéutica que contiene apomorfina como principio activo | |
CR20150309A (es) | Formulaciones de preservación de tejidos y órganos con incremento de estabilidad y vida propia | |
BR112012012649A2 (pt) | agente indutor de beta-defensina humana, formulação, e, usos de um agente indutor de beta-defensiva humana, e de pelo menos uma gordura ou óleo de um triglicerídeo de ácido graxo essencial ou de um derivado do mesmo. | |
PE20141068A1 (es) | Formulaciones topicas de tipo suspension que comprenden depsipeptido ciclico | |
BR112014020271A8 (pt) | Composição farmacêutica e métodos para diminuir a frequência de micção em paciente | |
GT200900235A (es) | Composiciones farmaceuticas | |
GT200700020A (es) | Compuestos y derivados de dibencilamina | |
WO2013055062A3 (ko) | 아밀알코올 또는 그 이성질체와 천연 식물성 오일 지방산을 에스테르화 시킨 화장료 조성물 | |
PH12015500793A1 (en) | Control agent for plant pest and/or plant disease | |
MY186572A (en) | Use of fatty acid ester for improving the antimicrobial efficacy of an alcoholic disinfectant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20200710 |